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Abstract
Since  genetic  engineering  of  pigs  can  benefit  both  biomedicine  and  agriculture,  selecting  a  suitable  gene
promoter  is  critically  important.  The  cytomegalovirus  (CMV)  promoter,  which  can  robustly  drive  ubiquitous
transgene expression,  is  commonly used at  present,  yet  recent  reports  suggest  tissue-specific  activity in the pig.
The objective of this study was to quantify ZsGreen1 protein (in lieu of CMV promoter activity) in tissues from
pigs harboring a CMV-ZsGreen1 transgene with a single integration site.  Tissue samples (n=35) were collected
from  neonatal  hemizygous  (n=3)  and  homozygous  (n=3)  piglets  and  ZsGreen1  abundance  was  determined via
immunoblotting.  ZsGreen1  was  detected  in  all  tissues,  except  hypothalamus,  kidney  cortex  and  oviduct.  The
expression  patterns  of  homozygous  and  hemizygous  piglets  were  similar  (P>0.05).  However,  quantification
revealed that ZsGreen1 protein levels were tissue-specific. Within neural/endocrine tissues, ZsGreen1 abundance
was highest in the anterior pituitary gland, intermediate in the cerebellum and lowest in the cerebrum, spinal cord
and posterior pituitary (P<0.05). In the digestive system, ZsGreen1 was more abundant in the salivary gland than
esophagus,  stomach,  pancreas,  duodenum,  jejunum,  ileum,  spleen,  colon,  gallbladder  and  liver  (P<0.05).
Interestingly,  ZsGreen1  amounts  also  differed  within  an  organ  (i.e.,  the  right  ventricle  had  3-fold  higher  levels
than the other heart chambers; P<0.05). These results provide useful information for the use of the CMV promoter
to  drive  transgene  expression  in  the  pig.  Moreover,  this  swine  model  represents  a  novel  resource  of  ZsGreen1-
labeled organs and a valuable tool to advance genome editing research.
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Introduction
The  use  of  genetically  engineered  pig  models  has
grown  dramatically  in  recent  years[1].  Transgenic
swine  are  increasingly  utilized  as  animal  models  for
human  diseases  since  they  are  anatomically,
physiologically  and  phylogenetically  more  similar  to
humans  than  rodents[1].  In  addition  to  biomedical
applications,  genetically  engineered  pigs  are  also
developed  to  better  understand  porcine  physiology
and enhance the agricultural industry[2–4]. Towards this
end, our laboratory produced a line of swine harboring
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a  vector  that  contained:  1)  the  human  U6  promoter
fused  to  small  hairpin  RNA  (shRNA)  specific  to  the
porcine gonadotropin-releasing hormone II (GnRH-II)
receptor  and  2)  the  human  cytomegalovirus  (CMV)
promoter fused to the cDNA encoding the fluorescent
protein,  ZsGreen1[2].  Previously,  we  evaluated  the
impact  of  GnRH-II  receptor  knockdown  (70
reduced  testicular  mRNA  levels)  on  reproductive
characteristics of male pigs[2]. Herein, we focus on the
human CMV promoter and ZsGreen1 reporter aspects
of this unique swine strain.
ZsGreen1  (Clontech,  USA)  is  derived  from
Anthozoa  reef  coral  (Zoanthus species)[5] and
modified  to  maximize  expression,  solubility  and
prompt  chromophore  maturation[6].  It  is  both
structurally  and  functionally  distinct  from  other
fluorescent  proteins,  like  green  fluorescent  protein
(GFP). The coding sequence of ZsGreen1 is only 26
homologous  to  GFP[5] and  ZsGreen1  exists  as  a
tetramer,  whereas  GFP  (derived  from  luminescent
jellyfish)  is  a  monomer[6].  Functionally,  ZsGreen1
displays  extremely  bright  fluorescence[7–8].  In  fact,
yeast  cells  expressing  ZsGreen  exhibit  8.6-fold
brighter  fluorescence  than  those  expressing  enhanced
GFP (EGFP)[7]. In addition, ZsGreen1, exhibiting high
signal-to-noise  ratio[7],  is  highly  photo-stabile  and
unaffected  by  paraformaldehyde  fixation[8].  Despite
these advantages, no transgenic swine lines containing
a ZsGreen1 reporter have been produced.
The  human  CMV  immediate  early  promoter,
discovered  by  Boshart  and  coworkers[9],  has  been
heavily utilized to drive recombinant gene expression
due to its constitutive and promiscuous nature[10]. The
CMV  promoter,  now  the  most  commonly  used  and
most robust ubiquitous promoter[11], is utilized to drive
transgene  expression  in  numerous  vertebrate  animal
models including sheep[12–13], fish[11], mice[14–15], rats[16],
chickens[17] and  pigs[18–19].  Pigs  harboring  a  construct
containing  the  CMV  promoter  fused  to  GFP  express
the  transgene  in  a  wide  range  of  organs,  including
those  derived  from  each  of  the  3  germ  layers:  skin
(ectoderm),  pancreas  (endoderm),  and  kidney
(mesoderm).  Despite  apparent  universal  transgene
expression[19],  the  CMV  promoter  is  preferentially
active  in  exocrine  compared  to  non-exocrine  cells  of
the pig[18]. The objective of this study was to quantify
ZsGreen1  protein  levels  (in  lieu  of  CMV  promoter




All  animal  procedures  followed  the  guidelines  for
the  care  and  use  of  animals  established  by  the
University  of  Nebraska –Lincoln  (UNL)  Institutional
Animal  Care and Use Committee.  These experiments
utilized  transgenic  swine  that  expressed  ZsGreen1
controlled  by  the  human  CMV  immediate  early
promoter and were generated as previously described[2].
Briefly,  transgenic  piglets  were  produced  by  micro-
injection  of  lentiviral  particles  into  the  perivitelline
space  of  1-cell  porcine  embryos.  Lentiviral  particles
were  made  using  the  Lenti-X  pLVX-shRNA2  vector
and  the  HTX  Packaging  Mix  (Clontech).  The  vector
contains  2  ubiquitous  promoters,  CMV  (driving
ZsGreen1  expression)  and  the  human  U6  promoter
(controlling  the  expression  of  a  shRNA  specific  for
the  GnRHR-II  gene).  The  background  strain  was  a
Large  White  ×  Landrace  composite  line  (Nebraska
Index  line)  developed  and  maintained[20] at  the  UNL
Eastern  Nebraska  Research  and  Extension  Center
swine  unit  (Mead,  NE,  USA).  Animals  from  this
background  strain  were  transported  to  the  UNL
Animal  Science  Building  (Lincoln,  NE,  USA)  and
used  to  derive  the  CMV-ZsGreen1  transgenic  line  of
pigs.  This  genetically-engineered swine line has been
expanded, maintained and studied within the confines
of the UNL Animal Science Building. In hemizygous
animals, one copy of the CMV-ZsGreen1 transgene is
stably  integrated  on  chromosome  14[2],  and  has
remained  transcriptionally  active  throughout  the
lifetime  of  the  founder  animal  and  in  10  subsequent
generations.
Adult  animals  were  housed  individually  with ad
libitum access  to  water  and fed approximately 2.5  kg
of feed daily. Hemizygous CMV-ZsGreen1 transgenic
sows  were  artificially  inseminated  with  semen  from
non-littermate  hemizygous  transgenic  boars  and
allowed  to  gestate  to  term.  Following  Mendelian
inheritance,  these  matings  yielded  hemizygous,
homozygous  (2  copies  of  the  transgene),  and  non-
transgenic  (control)  littermates  in  the  proportions
expected  with  a  single  integration  site.  After
farrowing,  piglets  remained  with  their  dam  to  suckle
ad libitum.
At 1 day of age, 3 littermate female piglets (control,
hemizygous  transgenic  and  homozygous  transgenic)
were selected from each of the 3 different litters; each
litter  was  produced  from  a  different  dam  and  sire
mating  to  maximize  genetic  diversity.  Initially,
transgene  status  was  assessed via evaluation  of
ZsGreen1  expression  using  an  ultraviolet  (UV)  light
and a Roscolux #15 filter (deep straw; Rosco, USA). 
Tissue collection
Piglets  were  first  sedated with  a  mixture  of  telazol
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(Zoetis,  USA),  atropine  (VetOne,  USA),  rompun
(Bayer,  USA)  and  ketamine  (VetOne)  (TARK;  0.2
mg/kg  atropine,  0.8  mg/kg  rompun,  3.1  mg/kg
ketamine  and  0.8  mg/kg  telazol)  delivered  intramus-
cularly in the neck (1 mL/18–23 kg of body weight).
Animals  were  then  euthanized via intracardiac
injection with Euthasol (1 mL/4.53 kg of body weight;
Delmarva  Laboratories,  USA).  Following  euthanasia,
tissue  samples  (n=35)  generally  representing  5
anatomical  regions  (brain,  thoracic,  digestive,  renal
and reproductive) were collected from each transgenic
piglet. Isolated tissues included: cerebrum, cerebellum,
spinal cord, anterior pituitary gland, posterior pituitary
gland,  hypothalamus,  thymus,  lymph  node,  the  four
chambers of the heart,  lung, muscle,  thyroid,  salivary
gland,  esophagus,  stomach,  duodenum,  jejunum,
ileum,  large  intestine,  gall  bladder,  spleen,  pancreas,
liver,  kidney  (medulla  and  cortex),  bladder,  adrenal
gland  (medulla  and  cortex),  ovary,  uterus,  oviduct,
and skin. Skin samples from control littermate piglets
were  collected  to  serve  as  a  negative  control  for
ZsGreen1  immunoblotting.  In  addition,  tail  samples
were  collected  from  all  piglets  for  genotyping.  All
samples  were  frozen  and  stored  at  −80  °C  until
analysis. 
DNA extraction
Genomic DNA was isolated from tail samples using
enzymatic digestion and phenol/chloroform extraction.
Briefly,  a  tail  slice  (approximately  1  mm)  was
incubated  overnight  in  a  lysing  solution  (50  mmol/L
Tris [pH 8.0],  150 mmol/L NaCl,  10 mmol/L EDTA,
1  sodium  dodecyl  sulfate  [SDS],  0.1  mg/mL
Proteinase  K  [Fisher  Bioreagents,  USA],  and  1  β-
mercaptoethanol) at 55 °C. The samples were extracted
twice  with  phenol:  chloroform:  isoamyl  alcohol  (25:
24:1)  solution  and  once  with  chloroform:  isoamyl
alcohol  (24:1)  solution  before  precipitating  the  DNA
with isopropanol. DNA was subsequently resuspended
in nuclease-free water. 
Genotyping
Since we previously identified a single transgene
integration  site  on  chromosome  14  (aligning  with
clone  NW_003612067.1  with  99  identity  and
matching identities 448 946–448 372) via sequencing
analysis  of  inverse  PCR  products  for  this  model[2],
copy  number  was  evaluated via conventional  PCR
using  3  primers.  The  forward  (F)  and  reverse  (R)
primers were designed to flank the insertion site of the
transgene,  and  an  additional  reverse  primer  aligning
the  transgene  (RT)  was  included  (F:  5 ′-GCAAC
CTCTTCGACACTCCA-3 ′;  R:  5 ′-AGCTACCAGGG
AACAAAGCC-3 ′;  RT:  5 ′-GGTTTCCCTTTCGCTT
TCAAGT-3′). An MJ Research PTC-200 Thermocycler
(USA) was used for PCR reactions with the following
conditions: 1× Taq Buffer A (Fisher Bioreagents) with
a  final  concentration  of  2.0  mmol/L  MgCl2,
200  μmol/L  dNTPs,  300  nmol/L  of  each  primer  and
1.25 U of Taq DNA Polymerase (Fisher Bioreagents).
Cycling  conditions  were  95  °C  for  2  minutes,
followed by 35 cycles of 95 °C for 30 seconds, 56 °C
for  30  seconds  and  72  °C  for  60  seconds  and  a  final
extension of 72 °C for 10 minutes. The resultant PCR
products  were  subjected  to  electrophoresis  on  1
agarose  gel.  Products  generated  from  the  F  and  R
primer pair were 627 bp in length and reflected a wild
type  chromosome 14.  Products  from  the  F  and  RT
primer  pair  resulted  in  an  847  bp  product,  indicating
that the transgene was present. 
Protein preparation
Protein  extraction  and  sample  preparation  were
performed  as  described  previously[21].  Protein  was
extracted  by  homogenization  of  tissue  samples  in
radioimmunoprecipitation  assay  (RIPA)  buffer
(1  mL/100  mg;  20  mmol/L  Tris,  137  mmol/L  NaCl,
10  glycerol, 1  NP40, 0.1  SDS, 0.5  deoxycholic
acid, 2 mmol/L EDTA, 1 mmol/L PMSF, 1  protease
inhibitor  cocktail  and  1  phosphatase  inhibitor
cocktail)  using  a  Biospec  Tissue  Tearor  (USA).
Protein  concentrations  were  quantified  using  a
bicinchoninic  acid  (BCA)  assay  (Pierce  Biotech-
nology,  USA)  according  to  the  manufacturer's
instructions.  Extracted  protein  was  mixed  with  4×
loading  dye  (2  Tris  [pH  6.8],  28  glycerol,  20
SDS and Orange G) containing 100 mmol/L DTT and
frozen at −80 °C until immunoblotting. 
Immunoblotting
Immunoblotting  was  performed  as  described
previously[21].  Tissue  samples  were  segregated  by
anatomical  regions  (brain,  thoracic,  digestive,  renal
and  reproductive)  and  protein  (10  or  20  μg)  was
separated  using  SDS-PAGE  (15 )  before  transfer  to
an Immobilon-FL polyvinylidene difluoride membrane
(Millipore,  USA) pre-soaked in methanol.  After  elec-
trophoretic  transfer,  nonspecific  binding  was  blocked
by  incubation  of  blots  in  Odyssey  Blocking  Buffer
(Cat.  No. 927-40100; LI-COR Biosciences, USA) for
approximately  3  hours  at  room  temperature.  Mem-
branes were then incubated with a mouse monoclonal
primary  antibody  directed  against  ZsGreen1  (1:1000;
Cat.  No.  632598;  Clontech),  diluted  in  Odyssey
Blocking Buffer with 0.05  Tween-20 and shaken at
4  °C  overnight.  The  following  morning,  membranes
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were  rinsed  in  Tris-buffered  saline  with  0.05
Tween-20  (TBS-T)  prior  to  incubation  with  a  goat
anti-mouse secondary antibody (1:15 000; IRDye 680;
Cat. No. 926-32220; LI-COR Biosciences) in Odyssey
Blocking  Buffer  plus  0.05  Tween-20  and  0.025
SDS  for  1  hour  at  room  temperature.  Blots  were
rinsed  with  TBS-T  to  remove  excess  secondary
antibody and briefly rinsed in TBS to remove Tween-
20 prior to imaging. 
Quantification of ZsGreen1 abundance
Blots were scanned on an Odyssey Infrared Imager
(700 channel; intensity 5.0; 169-micron resolution; LI-
COR  Biosciences)  and  converted  to  greyscale  for
analysis.  Band  density  was  quantitated  with  Odyssey
imaging  software  (version  2.1;  LI-COR  Biosciences)
which  automatically  subtracted  background  signal  to
determine  densitometry.  Since  the  abundance  of
common  loading  controls  (e.g.,  β-actin)  differed
across  tissue  types,  total  protein  levels  within  each
lane  were  used  as  the  loading  control  according  to
Eaton et  al[22].  After  ZsGreen1  imaging,  membranes
were  stained  with  GelCode  Blue  Safe  Protein  Stain
(ThermoScientific,  USA)  for  approximately  1  hour
and  then  rinsed  with  50  methanol  and  1  acetic
acid  solution  for  1  hour.  Blots  were  reimaged  (700
channel; intensity 1.0; 169-micron resolution; LI-COR
Biosciences),  converted  to  greyscale  and  quantitated
using  Odyssey  imaging  software  to  determine  the
relative  quantity  of  total  protein  present  in  each
sample.  Data  were  presented  as  the  relative  band
density  of  ZsGreen1  normalized  by  the  total  protein
levels within the entire lane as described previously[21].
The negative control in this experiment was wild-type
porcine  skin.  During  quantification,  ZsGreen1  was
considered  detectable  when  the  relative  band  density
of  the  transgenic  sample  was  greater  than  the  non-
specific  signal  detected  for  the  control,  which
inherently lacked ZsGreen1. ZsGreen1 was considered
undetectable  when  values  were  less  than  or  equal  to
the relative band density of the control sample. 
Statistical analysis
Analyses  were  performed  using  the  Statistical
Analysis  System  (version  9.4,  SAS  Institute  Inc.
USA). Analysis of variance (ANOVA) was performed
via the  MIXED  procedure  of  SAS  with  the  original
model including tissue type, genotype (hemizygous or
homozygous) and their interaction as the fixed effects.
There  was  no  effect  of  genotype  or  tissue  type  by
genotype  interaction  (P>0.05),  so  these  effects  were
removed from the statistical model; thus, homozygous
and  hemizygous  data  were  grouped  together  for  the
final  analysis.  Litter  was  included  in  the  model  as  a
random effect and P<0.05 was considered statistically
significant.  Results  were  presented  as  least  squares
means ± the standard error of the mean. 
Results
 
Identification  of  hemizygous  and  homozygous
CMV-ZsGreen1 transgenic piglets
The  presence  of  ZsGreen1  in  the  skin  of  neonatal
transgenic piglets was detected visually (Fig. 1A) and
via immunoblotting  (Fig.  1B),  indicative  of  CMV
promoter  activity.  Even  without  the  UV  light,  trans-
genic animals were identifiable via the yellow hue of
their  skin  (data  not  shown).  The  genotype  of  the
animals was confirmed by conventional PCR (Fig. 1D);
a  schematic  depicting  the  genotyping  method  is
available (Fig. 1C). ZsGreen1 was not detected in the
skin of control piglets (Fig. 1A and B). 
ZsGreen1  fluorescence  within  tissues  of  CMV-
ZsGreen1 transgenic piglets
ZsGreen1  fluorescence  was  visually  detectable
within internal organs of transgenic piglets under UV
light; fluorescence was absent in wild-type pig organs
(Fig.  2A;  right  panel).  Fluorescence  appeared  robust
in  the  intestines  (Fig.  2A;  middle  panel),  cerebellum
(Fig. 2B; left panel), anterior pituitary gland (Fig. 2B;
middle  panel)  and  heart  (Fig.  2B;  right  panel),  but
modest  within  the  stomach  (Fig.  2A;  middle  panel).
ZsGreen1 was not visually detectable in the cerebrum
(Fig.  2B;  left  panel),  posterior  pituitary  gland  (Fig.
2B;  middle  panel),  liver  or  spleen  (Fig.  2A;  middle
panel). Differential fluorescent patterns were observed
within  organs  as  well.  In  the  brain,  ZsGreen1
fluorescence  was  intense  within  the  cerebellum  but
not  visually  apparent  in  the  cerebrum  (Fig.  2B;  left
panel). In addition, the highest expression of ZsGreen1
appeared  in  the  right  ventricle  compared  with  the
other regions of the heart (Fig. 2B; right panel). 
Quantification  of  ZsGreen1  in  transgenic  porcine
tissues
 
Neural and endocrine tissues of the brain
Quantification  of  relative  band  density  indicated
that  ZsGreen1  was  present  in  5  of  the  6  tissues
examined  but  only  undetectable  within  the
hypothalamus (Fig. 3A). There was an effect of tissue
type on ZsGreen1 protein  levels  within  the  brain  and
the  nervous  system  (P<0.0001; Fig.  3A).  The
abundance  of  ZsGreen1  was  the  greatest  in  the
anterior pituitary gland, intermediate in the cerebellum
and lowest in the cerebrum, spinal cord and posterior
pituitary  gland  (P<0.05),  which  were  not  different
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from each other (P>0.05; Fig. 3A).
 
Thoracic tissues
ZsGreen1 was detected by immunoblotting in all  9
thoracic tissues evaluated. An effect of tissue type was
observed among the thoracic organs of CMV-ZsGreen1
piglets  (P<0.0001; Fig.  3B).  The  right  ventricle  and
skeletal  muscle  both  produced  more  ZsGreen1  than
the  other  tissues  within  the  thoracic  region  (P<0.05),
but did not differ from one another (P>0.05; Fig. 3B).
Levels  of  ZsGreen1  in  the  thyroid,  right  atrium,  left
atrium,  left  ventricle,  lung,  thymus  and  lymph  node
were similar to each other (P>0.05; Fig. 3B).
 
Digestive tissues
ZsGreen1  was  detected  in  all  11  digestive  organs
examined,  but  protein  levels  differed  among  tissue
types  (P<0.0001; Fig.  4).  The  ZsGreen1  level  in  the
salivary gland was greater than those in the esophagus,
stomach, pancreas, duodenum, jejunum, ileum, spleen,
large intestine, gall bladder and liver (P<0.05; Fig. 4).
Specifically, ZsGreen1 was 75-fold more abundant in
the  salivary  gland  compared  to  the  pancreas.  The
protein  amounts  in  the  esophagus  were  higher  than
those in  the pancreas,  ileum, spleen,  gall  bladder  and
liver (P<0.05), but not within the stomach, duodenum,
jejunum and large intestine (P>0.05; Fig. 4). ZsGreen1
levels  in  the  other  tissues  (stomach,  pancreas,
duodenum,  jejunum,  ileum,  spleen,  large  intestine,
gall  bladder  and  liver)  were  similar  to  each  other
(P>0.05; Fig. 4).
 
Renal and reproductive tissues
An effect of tissue type was observed among renal
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Fig.  1   Production  of  CMV-ZsGreen1  in  hemizygous  and  homozygous  transgenic  piglets. A:  Representative  photograph  of  control
piglet (left) with homozygous (middle) and hemizygous (right) transgenic siblings. ZsGreen1 was visualized with an ultraviolet light and a
Roscolux  #15  filter.  B:  Representative  immunoblot  of  ZsGreen1  in  the  skin  of  control  piglets  (n=3)  as  well  as  hemizygous  (n=3)  and
homozygous  (n=3)  transgenic  littermates.  Lower  panel  represents  total  protein  levels  within  each  lane.  C:  Schematic  demonstrating  the
genotyping  method  to  distinguish  among  control,  homozygous  and  hemizygous  piglets.  Detection  of  monoallelic  or  biallelic  transgene
integration was performed by conventional PCR using 3 primers. The forward primer, denoted by the black arrow, amplifies a non-coding
region upstream of the transgene integration site. A reverse primer (grey arrow) aligns a non-coding region downstream of the transgene and
a  second  reverse  primer  (indicated  in  green),  detects  the  transgene.  If  a  transgene  is  present,  the  resulting  PCR  product  will  be  847  bp;
however, in the absence of the transgene, the PCR product will be 627 bp. D: PCR detection of transgene integration and copy number. The
presence of only an 847 bp PCR product indicates a homozygous transgenic animal whereas a 627 bp product indicates a control animal. If
both 847 and 627 bp products are detected, the genotype is hemizygous transgenic.
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tissues  that  were  screened  (P=0.0001),  with  4  out  of
5  tissues  expressing  ZsGreen1.  We  were  unable  to
detect  ZsGreen1  within  the  kidney  cortex  (Fig.  5A).
The  medulla  region  of  the  adrenal  gland  produced
more  ZsGreen1  than  the  adrenal  cortex,  kidney
medulla and bladder (P<0.05; Fig. 5A). Abundance of
ZsGreen1  was  higher  in  the  adrenal  cortex  than  the
kidney  medulla  (P<0.05),  whereas  the  level  in  the
bladder  was  similar  to  that  in  both  tissues  (P>0.05;
Fig.  5A).  Within  female  reproductive  tissues,  we
detected ZsGreen1 protein in the ovary and uterus, al-
beit at reduced levels, but not in the oviduct (Fig. 5B).
However, no differences in ZsGreen1 abundance were
detected  between  the  ovary  and  uterus  of  female
transgenic piglets (P=0.4016; Fig. 5B). 
Discussion
In  accord  with  the  ubiquitous  nature  of  the  CMV
promoter,  ZsGreen1  protein  was  detected  in  all
porcine tissues examined, except in the hypothalamus,
kidney  cortex  and  oviduct.  Our  results,  however,
demonstrated  variable  levels  of  CMV  promoter
activity  across  organs  of  the  neonatal  piglet.  Other
researchers  observed  similar  results  in  animals
expressing  a  transgene  driven  by  the  CMV  pro-
moter[11,17–18,23].  Several  hypotheses  regarding  the
differential activity of the CMV promoter in vivo have
arisen.  The  activity  of  the  CMV  promoter  within  a
given  cell  type  may  be  influenced  by  integration
site[24];  namely,  activation  may  only  occur  in
transcriptionally  active  regions  of  the  genome[10].
Stochastic  silencing  can  happen  when  a  transgene  is
integrated  near  a  heterochromatic  region,  such  as  a
centromere[24],  or  when  multiple  copies  of  the
transgene  integrate  in  tandem[25],  due  to  local  for-
mation  of  heterochromatin[26].  Promoter  suppression
could  also  be  caused  by  methylation,  which  can
silence  transgenes in  vitro and in  vivo[12–14].  Furth et
al[23] observed  marked  differences  in  CMV  promoter
activity  across  tissues  in  two  transgenic  mouse  lines
harboring  the  same  transgene.  Conversely,  Vasey et
al[18] detected a similar CMV promoter activity profile
in pigs and chickens harboring the same transgene, alb-
eit  integrated  in  different  chromosomal  regions[18–19].
The  activity  patterns  were  also  similar  in  multiple
transgenic  chicken  lines  expressing  different  reporter
genes  directed  by  the  CMV  promoter[17].  Like  Vasey
et  al[18],  we  observed  widespread  CMV  activity
throughout  CMV-ZsGreen1  pigs  with  robust  activity
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Fig.  2   Visualization  of  ZsGreen1  fluorescence  within  internal  organs  of  transgenic  piglets. A:  Representative  image  of  ZsGreen1
fluorescence in the internal organs of control and transgenic piglets. The left panel represents internal organs from a transgenic piglet. The
middle panel represents a fluorescent image of internal organs from a transgenic piglet; and the right panel is a UV image of wild-type piglet
organs. B: Representative fluorescent images of a transgenic piglet brain (left panel), anterior and posterior pituitary glands (within the sella
turcica of the skull; middle panel) and heart (right panel). Anterior pituitary gland and posterior pituitary gland are indicated by white and
grey arrows, respectively. ZsGreen1 expression was abundant within the right ventricle of the heart (right panel). ZsGreen1 fluorescence was
detected with UV light and a Roscolux #15 filter. L: liver; St: stomach; Sp: spleen; I: intestines; Cr: cerebrum; Cl: cerebellum; AP: anterior
pituitary; PP: posterior pituitary; RA: right atrium; RV: right ventricle; LA: left atrium; LV: left ventricle.
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in  the  skin  and  salivary  glands,  despite  different
integration sites and transgenes.
In  addition  to  chromatin  status,  the  repertoire  of
transcription  factors  within  the  cell  dictate  CMV
promoter  activity[10].  Mella-Alvarado et  al hypothe-
sized  that  CMV  promoter  activity  was  robust  in  the
cells that were most voraciously infected by CMV and
reflective of optimal transcription factor expression[11].
Numerous  transcription  factors  have  been  implicated
in  the  regulation  of  the  CMV  promoter,  including
nuclear factor kappa-light-chain-enhancer of activated
B  cells[10,18,27],  yin  yang  1[10],  activator  protein  1  and
its  major  subunits  (c-Fos  and  c-Jun)[27],  p53,
cAMP  response  element-binding  protein/activating
transcription  factor,  retinoic  acid  receptor[28],
specificity  protein  1[9],  nuclear  factor  I,  serum
response  factor,  Elk-1  and  CCAAT/enhancer-binding
protein[29].  While  we  detected  different  ZsGreen1
protein  levels  between the  cortex  and medulla  within
the  kidney  and  adrenal  glands,  we  were  unable  to
comprehensively  evaluate  the  CMV-ZsGreen1
reporter among different cell types in this initial study.
Consistent with elevated CMV promoter activity in
exocrine  glands,  as  previously  noted  in  CMV-GFP
pigs[18], ZsGreen1 protein levels were increased in the
salivary  glands  of  transgenic  piglets.  In  the  pancreas,
however, we failed to detect elevated ZsGreen1 levels,
conflicting  with  other  reports  about  increased  CMV
promoter  activity  within  the  porcine  pancreas[18–19].
This  discrepancy  could  be  related  to  age-specific
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Fig. 3   Protein levels of ZsGreen1 within brain and thoracic tissues of CMV-ZsGreen1 piglets. A: Representative immunoblot of neural
and  endocrine  tissues  from CMV-ZsGreen1  transgenic  piglets  (n=6)  using  an  antibody  directed  against  ZsGreen1  (the  upper  panel).  The
middle  panel  represents  total  protein  levels  serving  as  the  loading  control.  Quantification  of  immunoblots  revealed  differences  in  relative
ZsGreen1 protein levels between tissue types (P<0.0001; the lower panel). B: Representative immunoblot of the thoracic tissue from CMV-
ZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The middle panel represents total protein
levels serving as the loading control. Quantification of immunoblots revealed differences in relative ZsGreen1 protein levels between tissue
types (P<0.0001; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05). ND: not detected.
Transgenic pig model expressing a CMV-ZsGreen1 reporter 169
activity  levels  of  the  CMV  promoter,  as  noted  in
zebrafish[11].  In  our  study,  neonatal  (1  day  of  age)
piglets  were  utilized,  whereas  others  examined  CMV
promoter activity in the pancreases of older (2 months
to  1  year  of  age)  pigs[18–19].  Likewise,  we  detected
robust  ZsGreen1  abundance  in  the  pancreases  of  1-
month  old  piglets  (unpublished  data).  Interestingly,
the pancreas is largely quiescent in the neonatal piglet;
the  production  of  pancreatic  juices  and  enzymes
increase dramatically after weaning[30]. In the liver, we
also  detected  little  CMV  promoter  activity.  Others
reported  similar  levels  of  CMV  promoter  activity  in
porcine  hepatocytes[18] and  chicken  liver[17],  although,
GFP  was  robustly  driven  by  the  CMV  promoter  in
hepatocytes of zebrafish[11].  Thus,  the CMV promoter
is  not  uniformly  effective  in  all  exocrine  organs  and
its activity varies across species.
Based  on  our  visual  observation  of  ZsGreen1
production  in  the  skin  of  hemizygous  and  homo-
zygous  piglets  (Fig.  1A),  we  hypothesized  that  an
additional  transgene  would  yield  more  ZsGreen1
protein  in  the  organs  of  homozygous  animals.
However, no genotype effect was detected based upon
quantification  of  immunoblots  for  ZsGreen1.  These
results  may  be  due  to  monoallelic  expression,  which
has  been  described  in  other  transgenic  animal
models[25,31].  Conversely,  translation  of  ZsGreen1
transcripts  may  be  impaired  in  homozygous  animals.
Post-transcriptional  silencing  of  high  expressing
transgenes  is  common  in  homozygous  (but  not
hemizygous)  plants  and  may  be  mediated  by  short
interfering  RNA[32].  Doubling  transgene  transcription
may  yield  copious  mRNA  transcripts,  breaching  a
threshold  that  triggers  cellular  processes  to  suppress
transgene  translation[33].  Nonetheless,  transgene  copy
number  did  not  significantly  affect  the  production  of
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Fig. 4   Protein levels of ZsGreen1 within digestive tissues of CMV-ZsGreen1 piglets. Representative immunoblot of digestive tissues
from CMV-ZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The middle panel represents
total  protein  levels  serving as  the  loading control.  Quantification  of  immunoblots  revealed  differences  in  relative  ZsGreen1 protein  levels
between tissue types (P<0.0001; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05).
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ZsGreen1 protein in this study.
Notably,  this  ZsGreen1 swine model  is  well  suited
for re-engineering the transgene locus since expression
of the transgene is readily detectable, the transgene is
present  in  a  single  copy  and  the  integration  site  has
been identified[2]. This swine line could be used to test
somatic cell gene editing using CRISPR/Cas9 systems
or  base  editor  nucleases  by  targeting  the  ZsGreen1
transgene sequence. In addition, the model is a useful
tool for testing germline genome editing approaches in
vivo such  as  Genome  editing via Oviductal  Nucleic
Acids  Delivery[34].  Finally,  re-engineering  the
transgenic  CMV-ZsGreen1  locus  of  this  pig  model
can  make  it  suitable  for  other  applications.  The
ZsGreen1 coding sequence can be disrupted to create
a  frameshift  mutation  in  ZsGreen1,  creating  a  model
as  a  reporter  for  homology  directed  repair  studies.
Alternatively,  a  floxed  red  fluorescent  protein  could
be inserted upstream of the ZsGreen1 cassette to serve
as  a  Cre  recombinase  reporter.  Re-engineering  of  the
locus  can  be  achieved via Easi-CRISPR,  a  highly
efficient genome engineering method[35].
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Fig. 5   Protein levels of ZsGreen1 within renal and reproductive tissues of CMV-ZsGreen1 piglets. A: Representative immunoblot of
the renal tissue from CMV-ZsGreen1 transgenic piglets (n=6) using an antibody directed against  ZsGreen1 (the upper panel).  The middle
panel represents total protein levels serving as the loading control. Quantification of immunoblots revealed differences in relative ZsGreen1
protein  levels  between  tissue  types  (P=0.0001;  the  lower  panel).  B:  Representative  immunoblot  of  the  reproductive  tissue  from  CMV-
ZsGreen1  transgenic  piglets  (n=6)  using  an  antibody  directed  against  ZsGreen1  (upper  panel).  The  middle  panel  represents  total  protein
levels serving as the loading control. Quantification of immunoblots indicated that there were no differences in relative ZsGreen1 abundance
between tissue types (P=0.4016; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05). ND: not detected.
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